Skip to content

Real-world study of symptom burden and health-related quality of life in patients with chronic graft-versus-host disease (cGVHD).

Real-world study of symptom burden and health-related quality of life in patients with chronic graft-versus-host disease (cGVHD).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108392
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-07
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic graft-versus-host disease after hematopoietic stem cell transplantation

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Allogeneic hematopoietic stem cell transplantation for the treatment of hematological diseases and the conditions for follow-up after transplantation; 2.Diagnosis of cGVHD by an outpatient physician during follow-up (diagnosis of cGVHD is mainly based on clinical signs, with reference to the diagnostic signs of the National Institutes of Health (NIH) consensus); 3.Self-reported presence of active cGVHD symptoms; 4.Follow-up age >= 16 years old, with basic literacy and comprehension skills; 5.Cooperate with follow-up personnel to voluntarily participate in this study;

Exclusion criteria

Exclusion criteria: 1.History of psychiatric illness, experiencing a serious life event, or insomnia before and after transplantation; 2.Non-exclusionary complications such as severe infection, poor implantation, and secondary tumors occurred during the investigation; 3.Recurrent hematologic disorders that do not achieve complete remission after induction therapy; 4.Transplant-related information records are insufficient or cannot be obtained from transplant case data from other hospitals;

Design outcomes

Primary

MeasureTime frame
LSS quantity and its differences;

Secondary

MeasureTime frame
Symptoms and differences in EQ-5D-5L;Symptoms and differences in SF-36 levels;Symptoms and differences in FACT-BMT quantity;

Countries

China

Contacts

Public ContactZhang Xi

The Second Affiliated Hospital of the Army Medical University of the People's Liberation Army of China

zhangxxi@sina.com+86 23 68763198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026